Private company

Codiak BioSciences, Inc.

American biological products company based in Cambridge, active since 2015.

Last updated Oct 18, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)
  • HeadquartersCambridge, United States
  • Incorporated inDE2
  • Business address35 Cambridgepark Drive, Suite 500, Cambridge, Ma 021402
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-303.2%Operating margin3
-162.0%Net margin3
686.8%Revenue growth, 20213
-69.4%Return on equity3
-$77.4MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Research and development96¢$64.9M
  • Interest4¢$2.7M

Out of $22.9M in revenue.3 The company lost money this year.

Financial statements

Revenue43$22.9M in 2021+5811% since 2019
0$10.0M$20.0M$30.0M2019: $388.0K$388.0K20192020: $2.9M$2.9M2020+651%2021: $22.9M$22.9M2021+687%
Operating income43-$69.5M in 2021−13% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M02019: -$80.2M-$80.2M20192020: -$90.9M-$90.9M2020+13%2021: -$69.5M-$69.5M2021−24%
Net income43-$37.2M in 2021−52% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M02019: -$78.0M-$78.0M20192020: -$91.7M-$91.7M2020+18%2021: -$37.2M-$37.2M2021−59%
Fiscal year2018201920202021
Revenue$388.0K4$2.9M3$22.9M3
Research and development$59.5M4$74.0M3$64.9M3
Operating income-$80.2M4-$90.9M3-$69.5M3
Interest$300.0K4$1.9M3$2.7M3
Income tax$04$03$03
Net income-$78.0M4-$91.7M3-$37.2M3

Compare Codiak BioSciences, Inc. with another company

Leadership

Who has led Codiak BioSciences, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Douglas E. Williams2020–2023

President

  1. Douglas E. Williams2020–2023

Chief financial officer

  1. Linda Bain2020–2023
2025
Board members and other officers (19)

Timeline

  1. Oct 13, 2020New chief executive Douglas E. Williams becomes CEO7
  2. Jun 11, 2015Founded Codiak BioSciences, Inc. is founded27

Filings

110 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 18 major events, 68 insider forms, 9 large holders, 10 other. The latest 20:

  1. Feb 14, 2024SC 13G/A EDGAR
  2. Apr 10, 2023SC 13G/A EDGAR
  3. Mar 30, 20234 EDGAR
  4. Mar 30, 20234 EDGAR
  5. Mar 30, 20234 EDGAR
  6. Mar 30, 20234 EDGAR
  7. Mar 30, 20234 EDGAR
  8. Mar 30, 20234 EDGAR
  9. Mar 29, 2023NT 10-K EDGAR
  10. Mar 29, 20238-K EDGAR
  11. Mar 27, 20238-K EDGAR
  12. Mar 3, 2023SC 13G/A EDGAR
  13. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  14. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  15. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  16. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  17. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  18. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  19. Feb 21, 20234 FORM 4 SUBMISSION EDGAR
  20. Feb 21, 20234 FORM 4 SUBMISSION EDGAR

The 110 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 9 such filings since October 2021:

  1. Feb 14, 2024SC 13G/A
  2. Apr 10, 2023SC 13G/A
  3. Mar 3, 2023SC 13G/A
  4. Feb 14, 2023SC 13G/A
  5. Feb 14, 2023SC 13G
  6. Feb 9, 2023SC 13G/A
  7. Feb 8, 2023SC 13G
  8. Sep 20, 2022SC 13D
  9. Feb 9, 2022SC 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27